Time for Endothelial Cell Proprotein Convertase PC5/6 in Cardiovascular Medicine?

Journal of Molecular Medicine - Germany
doi 10.1007/s00109-011-0810-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2017English

The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9

Pharmacological Reviews
Molecular MedicinePharmacology
2016English

T-Cell-Expressed Proprotein Convertase Furin Is Essential for Maintenance of Peripheral Immune Tolerance

Nature
Multidisciplinary
2008English

Directional and Balancing Selection on Proprotein Convertase Subtilisin/Kexin Type 6 (PCSK6)

2016English

Furin Is the Major Proprotein Convertase Required for KISS1-to-Kisspeptin Processing

PLoS ONE
Multidisciplinary
2014English

Lipoprotein(a) and Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors

Clinical Research in Cardiology Supplements
Nuclear MedicineRadiologyMolecular BiologyStructural BiologyImagingMedicine
2019English

Differential P1 Arginine and Lysine Recognition in the Prototypical Proprotein Convertase Kex2

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Biology of Endothelial Cells. Developments in Cardiovascular Medicine Series

British Journal of Cancer
Cancer ResearchOncology
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy